Buy LL-37 — Vendor Comparison & Prices
Compare LL-37 prices across verified research peptide vendors. See live pricing, COA testing results, discount codes, and shipping speeds. Updated regularly.
LL-37 is the only known human cathelicidin antimicrobial peptide, produced by neutrophils and epithelial cells as part of the innate immune response. It is studied for its roles in immune modulation, wound healing, angiogenesis, and defense against bacterial biofilms. This data reveals the dose amounts, vial sizes, and bacteriostatic water volumes researchers most commonly select when setting up their LL-37 reconstitution protocol.
Where to Buy LL-37 for Research
Finding a trustworthy LL-37 supplier requires comparing more than just sticker price. Vendors differ in vial size, peptide concentration, COA frequency, lab selection, and shipping speed. WPA aggregates this data into a single, filterable comparison so researchers can quickly identify the best overall value for LL-37 without visiting each vendor individually.
All LL-37 vendors listed on WPA have been reviewed for COA availability. We prioritize suppliers who publish independently verified purity results from named third-party laboratories with recent test dates.
What This LL-37 Comparison Page Includes
- Live LL-37 pricing — Current prices across all tracked vendors, normalized to price per milligram for a fair apples-to-apples comparison regardless of vial size.
- COA verification data — Third-party purity test results for LL-37, including the lab name, purity percentage, and test date so researchers can assess source quality.
- Vendor discount codes — Exclusive WPA researcher discount codes that reduce the cost of LL-37 from participating vendors.
- Vial size and strength comparison — LL-37 is sold in multiple concentrations and formats. WPA compares available strengths so lower vial prices do not conceal a higher true cost per milligram.
- Stock availability — Real-time in-stock status for LL-37 listings so researchers can plan sourcing without delays.
- Shipping and handling context — Smaller vials may require more frequent purchases, each with shipping costs. WPA surfaces total research cost context beyond vial price alone.
LL-37 Vendor Selection Methodology
WPA evaluates LL-37 suppliers on four primary criteria: COA quality (purity ≥98%, named independent lab, recent test date), pricing transparency (per-milligram cost clearly disclosed), stock reliability (consistent availability tracked over time), and community trust (based on anonymized researcher click and purchase data collected through WPA tools).
Vendors that cannot provide verifiable third-party testing for LL-37 are flagged accordingly. Researchers are encouraged to cross-reference COA data against the lab's published results before placing an order.
Frequently Asked Questions: LL-37 Sourcing & Pricing
Why compare LL-37 by price per milligram instead of vial price?
Vendors offer LL-37 in different vial sizes and concentrations. A lower vial price may contain less total peptide, resulting in a higher cost per milligram. WPA normalizes all LL-37 listings to $/mg so researchers see the true comparative value across all suppliers and strengths.
What should I check in a LL-37 COA before purchasing?
A valid LL-37 certificate of analysis should include the purity percentage (ideally 98% or higher), the name of an independent third-party laboratory, a recent test date (within the last 12 months), and the actual measured mass relative to the label claim. COAs without a named lab or with outdated test dates are red flags regardless of the purity figure listed.
How often does WPA update LL-37 vendor data?
World Peptide Association monitors LL-37 pricing and stock status continuously. COA verification status is updated whenever vendors publish new lab results. Researchers can check the "COA date" column on this page to see how recently each vendor's LL-37 testing was performed.
Why do LL-37 prices vary between vendors?
LL-37 price variation reflects differences in vial size, synthesis source, testing frequency, and vendor business model. Suppliers investing in frequent independent COA testing and quality control typically have higher baseline costs. WPA's per-milligram normalization helps researchers identify whether a lower price represents genuine savings or simply a smaller vial.